Patients taking warfarin should limit or avoid drinking cranberry juice because of the risk of hemorrhage.
British drug safety experts on the Committee on Safety of Medicines said it had received five reports, including one where the patient died, suggesting the juice and drug interact, increasing the potency of the drug.
"Until this possible interaction between cranberry juice and warfarin has been investigated further, it would be prudent for patients taking warfarin to be advised to limit or avoid drinking cranberry juice," the committee said.
The fatal case involved a man whose international normalized ratio (INR) dramatically increased to more than 50 six weeks after he started to drink cranberry juice, it reported in its newsletter "Current Problems in Pharmacovigilance."
The man died from gastrointestinal and pericardial hemorrhage.
In two other cases, less dramatic INR increases were noted while patients were taking cranberry juice. "In one of these the patient was stabilised on a lower dose of warfarin and in the other the INR returned to the therapeutic range after stopping cranberry juice," the report said.
According to the committee, the interaction is biologically plausible since cranberry juice contains antioxidants that inhibit cytochrome P450 activity, and warfarin is mainly metabolized by the P450 isoform CYP2C9.
Cranberry juice has boomed in popularity in recent years and is often used by women to prevent cystitis.
Did YOU KNOW:
Air Pollution Directly Related to Blood Pressure
Air pollution exposure is associated with an increased risk of acute and chronic cardiovascular mortality.
Brazilian researchers investigating the effect of urban pollutants on people directing road traffic in Sao Paulo, Brazil, have concluded that blood pressure levels are directly related to air pollution levels.
Their results, reported at this year’s ESC, confirm those of previous studies, but the researchers believe theirs are more accurate, since they were obtained using a 24-hour blood pressure monitoring. Annual Congress of the European Society of Cardiology (ESC), held August 30-September 3 in Vienna, Austria